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AbstrAct
Introduction In 2004, nearly 11 million severely burn-
injured patients required medical care worldwide. Burns 
cause prolonged hospitalisation and long-term disability. 
Although mortality has been reduced, morbidity remains 
significant.Burn care is costly and decision-making is 
challenging. A range of procedures are performed at 
different times after injury; new technology is emerging 
and alternate care pathways are regularly introduced. 
Data to guide evidence-based decision-making are 
lacking. Researchers use different outcomes to assess 
recovery, so it is not possible to combine trial information 
to draw meaningful conclusions. Early recovery measures 
include length of hospital stay, healing time and treatment 
complications. Longer-term outcomes include issues with 
function, cosmesis and psychological health. Reporting an 
agreed set of the most important outcomes (core outcome 
set (COS)) in randomised controlled trials (RCTs) will allow 
effective evidence synthesis to support clinical decisions. 
Patient input will ensure relevance.
Methods and analysis The aim is to produce a burn COS 
for RCT reporting. A long list of outcomes will be identified 
through systematic reviews of clinical and patient-reported 
outcomes. Additional outcomes will be identified from 
interviews with patients over 10 years, parents of children 
of any age and multidisciplinary professionals. A two-stage 
modified Delphi exercise will be undertaken to prioritise 
and condense the list, with patients (n=150) at different 
stages of recovery. We will also include nursing, therapy 
(n=100) and medical staff (n=100). A reduced list will be 
taken to consensus meetings with families and clinical 
staff to achieve a final COS.
Ethics and dissemination A COS will reduce outcome 
reporting heterogeneity in burn care research, allowing 
more effective use of research funding and facilitating 
evidence synthesis and evidence-based clinical decision-
making. Stakeholders will include journal editors, health 
commissioners, researchers, patients and professionals. 
The study has ethical approval and is registered with Core 
Outcome Measures in Effectiveness Trials Initiative (http://
www. comet- initiative. org/ studies/ details/ 798? result= true).
IntroductIon
A burn is an injury to the skin or other tissue, 
primarily caused by heat or otherwise by 
radiation, radioactivity, electricity, friction or 
contact with chemicals.1 Globally in 2004, the 
incidence of burns severe enough to require 
medical attention was nearly 11 million 
people.2 From 1 January 2003 to 31 December 
2011, 81 181 patients were referred for assess-
ment and admission to burn services in 
England and Wales, of which 57 801 required 
admission.3 Burns are the fourth leading 
cause of injury-related hospitalisation among 
young children.4
Burns cause morbidity, prolonged hospi-
talisation and disability.5 6 The primary aim 
of burn care is to achieve survival and then 
to restore function and cosmesis, while mini-
mising pain and any psychological impact. 
Improvements in care in higher-income coun-
tries have decreased mortality rates to close to 
zero. In the USA, the age-adjusted death rate 
from fire and burns has dropped from 2.99 
per 1 00 000 in 1981 to 1.2 per 1 00 000 in 
2006.2 Similar trends in mortality are seen in 
Europe and the UK.3 7 8 Morbidity however 
remains significant and attention has shifted 
to assessing other outcomes as markers of 
quality of care.9 Short-term outcomes include 
length of hospital stay, healing time, compli-
cations of treatment, infection rates and 
healthcare costs.10 11 Longer-term outcomes 
are associated with function (related to 
contractures),12 13 cosmesis (scarring),6 14 
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Protocol
Strengths and limitations of this study
 ► A core outcome set will improve evidence synthesis 
in burn care.
 ► The study achieves stakeholder engagement from 
multidisciplinary clinical staff and patients.
 ► There is international professional input.
 ► The outcomes chosen will need to reflect different 
stages of recovery after burn injury and different 
patient ages.
 ► Outcome measurement tools will need to be 
identified to assess the outcomes chosen.
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health-related quality of life,15 16 pain, itch and psycholog-
ical health.17–19 Injuries also affect families in terms of the 
social reintegration of the patient and managing absence 
from schooling or work. Most studies evaluating burn care 
focus on clinician-led short-term outcomes. While useful, 
it is important to consider longer-term, patient-centred 
outcomes. Outcome importance may also be affected by 
time after injury and patient age.
The diversity in treatment options make decision-making 
in burn care challenging. Burn care is also costly.11 20 21 
New treatment technologies regularly evolve offering the 
possibility of alternative care pathways with procedures 
performed at different times after injury. An evidence base 
is needed on which to base clinical decisions for the indi-
vidual or treatment for patient groups as a whole. One 
of the challenges with producing an evidence base and 
determining best care is establishing which outcomes 
should be used to inform clinical decisions. In burn care, 
this is hampered by the multiplicity of outcomes and time 
points used. It is also inhibited by a lack of agreement 
between professionals, limited patient involvement and 
varying national and international practice.22 23 The lack 
of consensus and consistency in outcome choice makes 
it difficult to compare and combine study results12 22 24 
with an increased risk of outcome reporting bias.6 25–30 A 
published literature search including 50 studies (1966–
2003) on short-term and long-term functional outcomes 
was unable to summarise current knowledge due to the 
variety of outcomes assessed.12 A Cochrane review of 30 
randomised controlled trials (RCTs) concluded that it 
was impossible to draw firm conclusions about the effec-
tiveness of burn dressings, as the studies summarised 
evaluated a variety of clinical end points.24 A systematic 
review on scarring identified 48 articles published since 
1965. Most had methodological limitations including 
a lack of standardised outcome measures, which was a 
major barrier to the authors drawing conclusions.6 Over 
the last 5 years, nine Cochrane reviews have had direct 
relevance to the management of patients with burns; five 
analysed less than six RCTs.24 31–38 None of the reviews 
could draw firm conclusions about the topic studied due 
to varying study design, poor reporting and risk of bias.
There have been few previous attempts to agree 
outcome measures for burn care. Authors in 2008 outlined 
seven core domains of outcome assessment.22 While an 
important contribution to the evidence, expert opinion 
was from one clinical team, with no input from patients. 
The British Burn Association (BBA) produced ‘Outcome 
Measures for Adult and Paediatric Burn Services’ in 
2013. This aimed to provide a toolkit for service internal 
audit and performance comparison rather than clinical 
trial reporting.39 Neither were designed, or have been 
adopted or used for research reporting and there is still a 
lack of agreement within the burns community about the 
measures chosen. There remains the need for consensus 
in burn outcome selection for RCT reporting.
One method to improve outcome reporting is to develop 
a core outcome set (COS), a minimum set of outcomes 
that are scientifically agreed and reported in all studies 
of a particular condition. The outcomes chosen must be 
measurable and relevant. Involving patients and other 
key stakeholders is key to achieving relevance. COS have 
improved outcome reporting in other healthcare trials. 
An observational review of 350 randomised trials for the 
treatment of rheumatoid arthritis identified through the 
Cochrane Library suggested that a higher percentage of 
researchers conducting trials in rheumatoid arthritis after 
the publication of the rheumatoid COS were reporting 
core outcomes.40 Another systematic literature search was 
undertaken to assess the uptake of COS domains in 123 
articles from 99 RCTs in spondyloarthritis care. These 
included 48 ‘before trials’ (trials prior to 2 years after 
publication of the COS) and 51 ‘after trials’ (published 
more than 2 years after COS publication).41 The authors 
found that 20% of the articles from the ‘after’ group and 
none from the ‘before’ group included all COS domains.
The aim of this study is to develop a COS for consis-
tent reporting of outcomes in RCTs relating to burn care 
interventions. There is currently no available COS for 
burn patients (http://www. cometinitiative. org/ studies/ 
search/). Determining a burn COS including early (clin-
ical efficacy) and longer-term (clinical effectiveness, 
patient centred) outcomes would positively affect the 
ability to provide evidence for clinical decision-making 
and ultimately improve patient care.42–47
Methods and analysIs
The study objectives are to:
1. Determine a comprehensive list of clinical and 
patient-reported outcomes;
2. Identify associated outcome measurement tools for 
future use in the development of a core measurement 
set;
3. Prioritise the outcomes from a patient and professional 
viewpoint;
4. Achieve consensus on a minimum set of relevant 
outcomes for burn RCT reporting (COS).
The study is a mixed-method design involving the use 
of qualitative and quantitative methodologies. A Delphi 
study, informed by literature reviews and qualitative inter-
view data, and consensus meetings will be undertaken to 
achieve consensus on outcome importance.
There will be four phases:
1. Identification of an outcome long-list through:
a. systematic literature reviews to identify clinical and 
patient-reported outcomes relevant to burn care;
b. semi-structured qualitative interviews to 
supplement the reviews.
2. Reduction of the long-list by grouping similar items 
together into domains to create questionnaire items;
3. Prioritisation of outcomes using Delphi methodology 
to achieve some consensus on stakeholders’ views of 
importance;
4. consensus meetings with patients and professionals to 
agree on the final COS.
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Inclusion criteria
Patients over the age of 10 years with a cutaneous burn 
of any size and type, parents of burned children of any 
age and any burn size and type from the UK and burn 
care professionals with 5 years or more experience from 
international settings.
exclusion criteria
Children of less than 10 years of age due to difficulties 
in younger children participating in interviews and inde-
pendently undertaking a questionnaire survey. Those who 
lack the capacity to consent to qualitative interviews or 
questionnaires. Those who do not speak or read English.
study setting
Qualitative interview patients and Delphi survey partici-
pants will be recruited from four geographically separate 
National Health Service (NHS) burn services and burn 
support groups. Professionals from a variety of disciplines 
will be recruited through the BBA and European Burn 
Association (EBA) and the International Society for Burn 
Injuries.
scope
The burn  COS will apply to RCTs evaluating therapeutic 
interventions for patients who have had cutaneous burn 
injuries. All therapeutic interventions directly impacting 
on burn care will be considered regardless of type, 
setting or mode of administration, including surgical and 
non-surgical care.
steering group
A steering group, including patients, parents, healthcare 
professionals, researchers, COS experts, journal editors 
and UK healthcare commissioners, has been formed to 
guide the development of the COS.
Phase 1: outcoMe long-lIst
All recently reported outcomes and outcome measure-
ment tools used in RCTs relevant to recovery after a 
cutaneous burn will be identified from systematic reviews 
of clinical and patient-reported outcomes and interviews 
with patients and professionals. The outcome measures 
will be kept for future development of a core measure-
ment set, but not analysed further at this stage.
systematic reviews
A systematic review of RCTs evaluating surgical and 
non-surgical burn care for patients with cutaneous burns 
will be undertaken using the Cochrane Register, Ovid 
EMBASE, Web of Science and Ovid MEDLINE to identify 
clinical burn outcomes. A second review will update and 
deconstruct published systematic reviews on patient-re-
ported outcomes after burns.48–50The objectives of the 
clinical outcome systematic review will be to:
i. identify all short-term and long-term clinical 
outcomes reported in prospective RCTs relevant to 
burn care;
ii. categorise the outcomes into outcome domains;
iii. summarise heterogeneity in outcome reporting in 
included studies;
iv. identify measurement tools used to assess the 
outcomes and record definitions.
Criteria for inclusion are published RCTs reporting clin-
ical interventions for patients of any age who have had 
a cutaneous burn injury of any type, any size and at any 
time. The definition of intervention includes surgical 
and non-surgical burn care with any appropriate compar-
ators. Clinical outcomes and outcome measurement tools 
are those relevant to the assessment of patients’ recovery 
and long-term well-being. These will include short-term 
outcomes including adverse events and complications of 
surgical and non-surgical care, longer-term outcomes and 
mortality/survival outcomes at all reported time points.
The search will be limited to the last 5 years, from 
1 January 2012 to 31 December 2016. A 5-year time 
period has been chosen so that the outcomes extracted 
reflect use in recent randomised trials relating to modern 
burn care. It will be limited to RCTs (as the final COS 
will be used for RCT reporting), English language publi-
cations and studies involving human subjects only. Pilot 
studies will be included where the full trial has not yet 
been published. Conference abstracts will be excluded. 
Due to the exploratory nature of the review, no studies 
will be excluded by quality.
Searches will use transparent selection criteria. The 
controlled vocabulary of Medical Subject Headings, 
including subheadings, publication types and supple-
mentary concepts, will be used. Free text (keywords) will 
also be applied, the term ‘burn*’ (truncation), scald* 
OR ‘thermal adj injur*’ OR smoke adj inhalation (see 
online supplementary appendix A for full details). Trials 
studying pure carbon monoxide poisoning or chemical 
ocular or caustic oesophageal burns will be excluded, as 
these are outside the scope of the review. RCTs where 
care for burned patients are a part of the trial popula-
tion will only be included if it is possible to separate out 
the outcomes of interest to burn patients. Trials assessing 
quality of life will be included, if the outcomes are observ-
er-reported and not patient-reported. The latter are part 
of a separate systematic review.
One reviewer will assess study abstracts and apply the 
inclusion and exclusion criteria and select studies. A 
second reviewer will independently assess 10%–20% of 
the abstracts and findings will be compared. The full text 
of papers meeting the inclusion criteria will be assessed 
in the same way. At each stage, reviewers will meet to 
ensure consistency of application of the inclusion criteria, 
with calculation of Cohen’s kappa to indicate reliability. 
Outcomes and measures used to assess the outcomes will 
be extracted from full texts using a standardised proforma 
based on the Cochrane Collaboration good practice data 
collection form and tested and refined. Study details: 
author(s), year and journal of publication, country 
and number of centres, intervention(s)/comparators 
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under investigation, population (participant numbers, 
age, gender and burn size (area) and depth), reported 
outcomes, outcome definitions, outcome measures and 
time point of measurement after injury will be recorded.
There will be no synthesis of outcome data from the 
included RCTs (because of the expected heterogeneity 
of outcomes) and hence a critique of the overall meth-
odological quality of the studies is not necessary. The 
intention of the review is to generate a comprehensive 
list of outcomes reported in recent RCTs researching 
modern burn care. Therefore, no studies will be excluded 
on the basis of quality.
The systematic review is registered on the Prospero 
database (Prospero ID CRD42017060908).
Qualitative interviews
Semi-structured interviews will be undertaken to identify 
outcomes to inform the long-list and supplement the liter-
ature reviews, with patients of more than 10 years of age, 
parents of children of any age, multidisciplinary staff and 
UK healthcare commissioners. The opinions of patients 
are important because it is patients and families that will 
experience the benefits and adverse effects of treatments.
Potential patient participants will initially be identi-
fied by four UK specialised burn services and associated 
burn support groups. Interviews will be conducted by one 
researcher only (AY) at a range of times after injury to 
capture different phases of recovery. Specifically, patients 
will be consulted within 6 months (early) and more than 
2 years after injury (late). No interview will be under-
taken within 1 month of injury or during an acute period 
of hospitalisation. Professional participants will include 
doctors of different background specialty, therapists, 
nurses and NHS commissioners identified through the 
BBA and EBA and International Society for Burn Injuries. 
The BBA has supported this project.
Interviews will be conducted face-to-face on a 
one-to-one basis to gather data on the importance of 
different outcomes after injury. Parents or carers will be 
invited to be present for interviews with children between 
the ages of 10 and 15 years of age if the children prefer 
this, although a focus on the experience and self-reports 
of the children themselves will be maintained whenever 
possible. Patients will be given no information about the 
clinical experience of the interviewer, so that the impact 
of the researcher’s knowledge is minimised. The inter-
views will be recorded and transcribed verbatim. Field 
notes will also be taken. The interview topic guides will 
be informed by the data emerging from the systematic 
reviews. They will be developed and piloted with patient 
and professional representatives. Questions will be open 
and led by participants. Patients will also be encouraged 
to introduce and discuss topics that are most important to 
them. Discussion will focus on issues of particular salience 
to patients and professionals during both treatment 
for and recovery from a burn injury. All aspects of the 
patients’ life will be covered, including but not limited 
to those affecting function, cosmesis and psychological 
health. Recovery outcomes affected by healthcare treat-
ment and issues affecting daily life at different time points 
after injury will be discussed. Consideration will be given 
to the non-inclusion of outcomes that are mentioned 
rarely or only once by participants in interviews.
sample size
Sample size will be determined by data saturation.51 
Interviews will continue until no further new outcomes 
are obtained and diversity in the sample is achieved. In 
line with guidance from Braun and Clarke,52 a diverse 
group of patients will be used to obtain rich and mean-
ingful data.52 A sample of 30–40 patients is anticipated 
based on previous studies, but this will be increased 
if any new outcomes are discussed in the final inter-
views. Non-probabilistic purposive sampling will ensure 
maximum variation based on patient age, sex, ethnicity, 
burn severity (size and depth), aetiology, time after injury, 
management at different burn services and professional 
clinical experience and specialty. Ethnic and demo-
graphic diversity of the populations in the recruitment 
centres will be maximised.
data analysis
A thematic analysis will be undertaken. Descriptive 
accounts will be written up relating to each batch of 
interviews. The data will be checked for validity and 
contextual accuracy. The transcribed interviews will be 
read through to get an overview of the collected data. 
Following a systematic approach to coding, a framework 
method of data management will be used to chart coded 
data.53 Transcripts will be reviewed line by line after each 
interview and words, phrases and passages related to 
important outcomes during recovery or burn care will 
be coded using NVivo software. Coding will be under-
taken by one researcher with a second reviewer coding 
10% of interviews to assess agreement. A number of 
quotes and assigned codes will be checked by two patient 
representatives. We will also ask these patients to read a 
percentage of uncoded transcripts and suggest codes or 
themes. Preliminary codes will be reviewed and the final 
analytical codes will be applied and grouped into themes. 
Data analysis will run in parallel with collection so that 
themes can be used to input in an iterative manner into 
subsequent interviews. The interviews will proceed until 
data saturation. Findings from qualitative interviews will 
be disseminated as soon as possible to clinicians and 
policy makers.
The interview outcome data will be combined with the 
outcomes from the literature reviews into a comprehen-
sive long-list of potential outcomes.
Phase 2: QuestIonnaIre desIgn
Outcome domains are defined as broad concepts that 
group individual outcomes together.43 54–56 The long-list 
will be condensed by grouping similar outcomes into 
domains. Duplicated items will be removed. Clinical and 
patient-reported items will be included. Domains will be 
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identified independently by two researchers and a small 
number of patients in discussion with a third senior 
researcher if there are discrepancies. The shorter list of 
domains will be operationalised into questionnaire items; 
one domain will be one question. The same plain English 
version of the questionnaire with medical terminology in 
parentheses will be used for both stakeholder groups.57 
The questionnaire will be designed with patient repre-
sentatives to ensure understanding and acceptability and 
piloted with patients, parents and healthcare staff prior to 
use. Consideration will be given to randomising the ques-
tion order as evidence suggests that this may impact on 
reported outcome importance.58
Phase 3: delPhI survey
A Delphi method is commonly chosen as a way to achieve 
consensus for COS.59–61 It is less expensive and overcomes 
some of the limitations found with decision-making 
processes in groups or committees. Performing an anon-
ymous Delphi study by email may avoid dominance of 
certain persons in face-to-face group meetings and feed-
back is provided in a controlled manner.
Patients, parents and healthcare staff in this study will 
be asked to prioritise the outcome questions in terms of 
importance through a Delphi survey. Questionnaires will 
ask participants to rate outcome importance on a Likert 
scale ranging from ‘not that important’ (0) to ‘critical’ (9) 
for inclusion.62 63 Participants will receive an email linking 
to the questionnaire embedded in the study website. If 
their preferred method of contact is written, a paper copy 
will be sent. The questionnaire will be used in three survey 
rounds. This will allow us to keep all outcomes in the first 
two rounds with feedback enclosed within the second 
round. We will only reduce the outcomes in the third 
and final questionnaire survey. Repeated reflection and 
scoring will also increase the likelihood of stakeholder 
convergence.26 The Delphi survey will be conducted with 
clinicians, nurses and therapists from UK burn services 
as well as through the BBA, EBA and International Burn 
Association. Patients and parents will be approached 
through four UK burn services and support groups. 
Patients (of more than 10 years of age) will be recruited 
early after injury (n=50) and at more than 2 years after 
injury (n=100).
sample size
There is no robust method for calculating the required 
sample size for a Delphi survey and assumptions are 
based on Core Outcome Measures in Effectiveness 
Trials (COMET) Initiative guidelines and previous 
studies.64 65 The aim would be to recruit 150 patients 
along with 100 nurses and therapists and 100 clinicians 
and NHS personnel.
Consenting (assenting) participants will receive an 
email linking to the questionnaire which will be avail-
able online. After each round, results will be fed back to 
participants in a subsequent questionnaire to allow them 
to reprioritise outcomes and consider the views of others. 
The feedback will show for each item that participant’s 
previous score and score from their stakeholder group 
and other stakeholder groups presented as the median 
and IQR or as a histogram. The feedback is crucial to 
achieve consensus. The method of feedback is important 
and will be discussed with the patient and parent repre-
sentatives prior to the Delphi survey. At the end of the 
first survey, participants will be allowed to add any addi-
tional outcomes that they feel are important. These will 
be added to round 2 if stated by more than one partici-
pant. All outcomes from round 1 will remain in round 2 
to allow participants to reconsider all the outcomes with 
the feedback attached. Outcomes considered essential at 
the end of round 2 will be retained to round 3. Essential 
outcomes will be defined as: outcomes rated 7–9 by 50% 
or more of participants and 1–3 by less than 15% among 
either patients or professionals.63 Outcomes not meeting 
this criteria will be discarded.
Participants will then re-score each outcome retained 
in round 3. Items taken forward to the consensus meet-
ings will include those meeting the following criteria: 
outcomes rated 7–9 by 70% or more of participants and 
1–3 by less than 15% among either stakeholder group.26
These criteria will ensure that items where there 
remains strong disagreement (one stakeholder group 
feels strongly that an item should be retained but the 
other group disagrees) will be retained for further discus-
sion. In this way, items that are crucial to one stakeholder 
group will not be lost. The purpose of the Delphi is to 
reduce the number of potential outcomes; it is plausible 
that the above criteria applied at the end of rounds 2 and 
3 may fail to discard many outcomes. Hence, we will apply 
stricter criteria at the end of round 2 and/or at the end 
of round 3 if over 67% of items reach the initial criteria 
for retaining items. Stricter criteria for retaining items at 
the end of round 2 will be: outcomes rated 8–9 by 50% 
or more of participants and 1–3 by less than 15% among 
either patients or professionals. Stricter criteria at the end 
of round 3 will be: outcomes rated 8–9 by 70% or more 
of participants and 1–3 by less than 15% among either 
stakeholder group.66
Phase 4: consensus MeetIngs
Consensus meetings to finalise the COS will be held 
separately with patients/families and professionals (multi-
disciplinary clinicians, commissioners).63 Currently, it is 
unknown whether it is preferable to have joint patient and 
professional consensus meetings to finalise COS. We have 
chosen to hold separate meetings to allow free discus-
sion within the patient group without fear of professional 
views impacting on decision-making. We will explore with 
children and families how best to include patients of 
different ages and parents. Focus groups will be organised 
to discuss this in advance of the meetings. All participants 
who completed the Delphi survey will be invited to the 
consensus meeting, along with representatives from 
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patient groups and professional bodies. The aim will be 
to gather approximately 60 participants with an equal 
representation of patients and professionals attending 
separate meetings.63
The results of the Delphi survey will be presented at the 
consensus meetings. The retained outcomes from all the 
Delphi surveys will be presented to ensure a clear audit 
trail of decision-making is shown. Items retained after 
round 3 will be discussed in detail. Participants will be 
asked to rate each outcome as ‘in’, ‘out’ or ‘unsure’ for 
inclusion in the COS. Voting will be undertaken using 
electronic keypads to ensure anonymity. Feedback will be 
provided to participants in the form of descriptive statis-
tics. Where a similar number of participants vote ‘in’ and 
‘out’, issues will be explored by discussion to determine 
the nature of the polarised response. Voting will continue 
in iterative rounds until a two-thirds majority on ‘in or 
out’ is reached on all domains. The patient meeting 
will be held in advance of the meeting for professionals. 
Consideration will be given to presenting the patient 
decisions to the professionals. All items retained from the 
patient and professional meetings will be included in the 
final core set.67
ethIcs and dIsseMInatIon
Ethical approval has been granted by the South West—
Frenchay Research Ethics Committee (ref 17/SW/0025 
IRAS 221625). All participants involved will be asked 
for their consent before participation in the qualitative 
interviews and the Delphi survey, and the study will be 
conducted according to the Declaration of Helsinki.
This study aims to achieve a single COS for trial 
reporting relevant to patients and multidisciplinary 
professionals after cutaneous burn injury.26 A COS 
represents a minimum set of relevant outcomes that 
should be measured in a clinical trial for a particular 
condition. The intent is not to limit researchers but rather 
to provide them with a minimum list of outcomes to 
include in their trials along with others of their choosing. 
The burn COS will achieve this for burn care. This will 
improve the ability to undertake systematic reviews and 
develop a high-quality evidence base to improve clinical 
decision-making.
COS methodology is promoted and supported by the 
COMET initiative.64 65 There is however no gold standard 
for achieving consensus or reporting COS.68 Every COS 
therefore brings learning with regard to methodology. A 
particular difficulty with achieving a COS for burn care 
is the multiplicity of outcomes, including the potential 
varying importance of outcomes with age of patient and 
time after injury. This study will attempt to achieve a COS 
reflecting both short-term and longer-term outcomes 
for patients of different ages facilitating broad applica-
bility. If patient age is found to influence the relevance or 
importance of particular outcomes, consideration will be 
given to achieving a generic COS with age-related add-on 
modules.
One of the major challenges associated with the devel-
opment of a COS is ensuring impact and uptake. Impact 
for COS in general has been reflected by the Standard 
Protocol Items: Recommendations for Interventional 
Trials statement which recommends the use of COS where 
they exist.69 70 The National Institute for Health and Care 
Excellence also encourages the use of COS where avail-
able during evidence scoping and synthesis. The National 
Institute for Health Research Health Technology Assess-
ment funding body has recently added the following 
statement to its application form: ‘Where established 
Core Outcomes exist they should be included among the 
list of outcomes unless there is good reason to do other-
wise’.
The choice of stakeholders is important to effect 
impact.63 The COS will be developed with active partic-
ipation of patients, professionals, journal editors, 
professional burn associations within the UK and further 
afield and representatives of NHS England. Professionals 
will be recruited from international settings. This will 
enable effective dissemination and ensure maximum 
impact. The chair of the Burn Injury Database has agreed 
to collaborate and to undertake work to include the final 
COS into the database. The COS has been registered with 
the COMET team who will also advise on maximising 
impact. Patient representatives will be fully involved 
throughout, undertaking the interviews and Delphi 
survey and advising on on-going project design.
Achieving COS in other healthcare areas has improved 
consistency of outcome reporting in trials.40 41 It is antic-
ipated that this COS will do the same for burn care 
research and thus improve the evidence base, clinical 
decision-making and outcomes for patients.
This article presents independent research funded by 
the National Institute for Health Research (NIHR). The 
views expressed are those of the authors and not neces-
sarily those of the NHS, the NIHR or the Department of 
Health.
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